Drug Development for Rare Diseases

<p>A disease is defined as rare if the prevalence is fewer than 200000 in the United States. It is estimated that there are more than 7000 rare diseases which collectively affect 30 million Americans. This diverse and complex disease area poses challenges for patients caregivers regulators drug developers and other stakeholders.</p>